October 13, 2025
LTS expands its CDMO capabilities with the acquisition of Renaissance Lakewood
Andernach– LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company today announces the acquisition of Renaissance Lakewood, LLC (“Renaissance”), a US-based contract development and manufacturing organization (CDMO) specializing in nasal sprays and sterile dosage forms.
READ MORE READ MORE